Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

Magdalena Biosciences, a joint venture between Filament Health and Jaguar Health, reported positive preclinical data showing a coca leaf extract prevented weight gain in mice without reducing food intake. The extract is being developed as a prescription drug for post-GLP-1 weight management under the FDA's Botanical Guidance, targeting the significant unmet need of weight regain after cessation of GLP-1 therapies.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.